Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier function. GUCY2C may represent a new target for anti-obesity pharmacotherapy. GUCY2C Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 50.01 kDa and the accession number is Q3UWA6-1.
规格 | 价格/CNY | 货期 | 数量 | |
---|---|---|---|---|
100 μg | ¥ 5,180 | 5日内发货 | ||
500 μg | ¥ 20,700 | 5日内发货 | ||
1 mg | ¥ 34,600 | 5日内发货 |
产品描述 | Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier function. GUCY2C may represent a new target for anti-obesity pharmacotherapy. GUCY2C Protein, Mouse, Recombinant (His & Avi), Biotinylated is expressed in HEK293 mammalian cells with C-His-Avi tag. The predicted molecular weight is 50.01 kDa and the accession number is Q3UWA6-1. |
种属 | Mouse |
表达系统 | HEK293 Cells |
标签 | C-His-Avi |
蛋白编号 | Q3UWA6-1 |
别名 | EC 4.6.1, Guanylyl cyclase C, MUCIL, GUC2CEC 4.6.1.2, GUC2C, STA receptor, GCC, STAR, GC-C, DIAR6, GUCY2C |
蛋白构建 | Val20-Met433 |
蛋白纯度 | > 95% as determined by Tris-Bis PAGE; > 90% as determined by HPLC |
分子量 | 50.01 kDa (predicted). Due to glycosylation, the protein migrates to 70-100 kDa based on Tris-Bis PAGE result. |
内毒素 | < 1 EU/μg by the LAL method. |
缓冲液 | Supplied as 0.22 μm filtered solution in PBS (pH 7.4). |
存储 |
It is recommended to store the product under sterile conditions at -70℃ or lower. Samples are stable for up to 12 months at -80℃. Please avoid multiple freeze-thaw cycles and store products in aliquots. |
运输方式 |
In general, Lyophilized powders are shipping with blue ice. Solutions are shipping with dry ice. |
研究背景 | Guanylyl cyclase C (GUCY2C) has canonical centrality in defense of key intestinal homeostatic mechanisms, encompassing fluid and electrolyte balance, epithelial dynamics, antitumorigenesis, and intestinal barrier function. GUCY2C may represent a new target for anti-obesity pharmacotherapy. |
bottom
您可能有的问题的答案可以在重组蛋白操作手册中找到
GUCY2C Protein, Mouse, Recombinant (His & Avi), Biotinylated EC 4.6.1 Guanylyl cyclase C MUCIL GUC2CEC 4.6.1.2 DIAR 6 GUC2C DIAR-6 STA receptor GCC STAR GC-C DIAR6 GUCY2C recombinant recombinant-proteins proteins protein